Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta

Zanjani, 1992, Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero., J Clin Invest, 89, 1178, 10.1172/JCI115701

Touraine, 1997, Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally., Transplant Proc, 29, 712, 10.1016/S0041-1345(96)00432-0

Flake, 1999, In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers., Blood, 94, 2179, 10.1182/blood.V94.7.2179.419k43_2179_2191

Westgren, 1996, Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies., Transplantation, 61, 1176, 10.1097/00007890-199604270-00010

Shields, 2002, Fetal hematopoietic stem cell transplantation: A challenge for the twenty-first century., J Hematother Stem Cell Res, 11, 617, 10.1089/15258160260194767

Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex., Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x

Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli., Blood, 99, 3838, 10.1182/blood.V99.10.3838

Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation., Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9

Rasmusson, 2003, Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells., Transplantation, 76, 1208, 10.1097/01.TP.0000082540.43730.80

Almeida-Porada, 1999, Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero., Exp Hematol, 27, 1569, 10.1016/S0301-472X(99)00090-9

Almeida-Porada, 2000, Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation., Blood, 95, 3620, 10.1182/blood.V95.11.3620

Liechty, 2000, Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep., Nat Med, 6, 1282, 10.1038/81395

in’t Anker, 2003, Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice., Exp Hematol, 31, 881, 10.1016/S0301-472X(03)00202-9

Airey, 2004, Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart., Circulation, 109, 1401, 10.1161/01.CIR.0000124222.16321.26

Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo., Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X

Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide., Blood, 101, 3722, 10.1182/blood-2002-07-2104

Gotherstrom, 2003, Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells., Bone Marrow Transplant, 32, 265, 10.1038/sj.bmt.1704111

Gotherstrom, 2004, Immunologic properties of human fetal mesenchymal stem cells., Am J Obstet Gynecol, 190, 239, 10.1016/j.ajog.2003.07.022

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells., Science, 284, 143, 10.1126/science.284.5411.143

Prockop, 1997, Marrow stromal cells as stem cells for nonhematopoietic tissues., Science, 276, 71, 10.1126/science.276.5309.71

Campagnoli, 2001, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow., Blood, 98, 2396, 10.1182/blood.V98.8.2396

Pereira, 1995, Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice., Proc Natl Acad Sci USA, 92, 4857, 10.1073/pnas.92.11.4857

Nilsson, 1999, Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice., J Exp Med, 189, 729, 10.1084/jem.189.4.729

Onyia, 1998, Osteoprogenitor cells as targets for ex vivo gene transfer., J Bone Miner Res, 13, 20, 10.1359/jbmr.1998.13.1.20

Devine, 2001, Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion., Exp Hematol, 29, 244, 10.1016/S0301-472X(00)00635-4

Devine, 2003, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates., Blood, 101, 2999, 10.1182/blood-2002-06-1830

Byers, 2001, The metabolic and molecular bases of inherited disease., 5241

Myllyharju, 2001, Collagens and collagen-related diseases., Ann Med, 33, 7, 10.3109/07853890109002055

Pereira, 1998, Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta., Proc Natl Acad Sci USA, 95, 1142, 10.1073/pnas.95.3.1142

Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta., Nat Med, 5, 309, 10.1038/6529

Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone., Proc Natl Acad Sci USA, 99, 8932, 10.1073/pnas.132252399

Korkko, 1998, Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of null-allele mutations., Am J Hum Genet, 62, 98, 10.1086/301689

Sillence, 1997, Emery and Pimoin’s principles and practice of medical genetics, vol. II., 2817

Astrom, 2002, Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta., Arch Dis Child, 86, 356, 10.1136/adc.86.5.356

Byers, 1991, Osteogenesis imperfecta: Translation of mutation to phenotype., J Med Genet, 28, 433, 10.1136/jmg.28.7.433

Wang, 1993, Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain: A regional model relating mutation location with phenotype., J Biol Chem, 268, 25162, 10.1016/S0021-9258(19)74583-9

Glorieux, 1998, Cyclic administration of pamidronate in children with severe osteogenesis imperfecta., N Engl J Med, 339, 947, 10.1056/NEJM199810013391402

Banfi, 2000, Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy., Exp Hematol, 28, 707, 10.1016/S0301-472X(00)00160-0

Fouillard, 2003, Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma., Leukemia, 17, 474, 10.1038/sj.leu.2402786

Rombouts, 2003, Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture., Leukemia, 17, 160, 10.1038/sj.leu.2402763

Spees, 2003, Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma., Proc Natl Acad Sci USA, 100, 2397, 10.1073/pnas.0437997100

Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells., Exp Haematol, 31, 890, 10.1016/S0301-472X(03)00110-3

Noort, 2002, Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice., Exp Hematol, 30, 870, 10.1016/S0301-472X(02)00820-2

Sillence, 1979, Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity., Birth Defects Orig Artic Ser, 15, 113

Bonadio, 1985, Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II., Nature, 316, 363, 10.1038/316363a0

Sokolov, 1993, Tissue- and development-specific expression in transgenic mice of a type I procollagen (COL1A1) minigene construct with 2.3 kb of the promoter region and 2 kb of the 3’-flanking region: Specificity is independent of the putative regulatory sequences in the first intron., Biochemistry, 32, 9242, 10.1021/bi00086a033

Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)., Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650